These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 1682035)

  • 1. Accumulation of genetic alterations and progression of primary breast cancer.
    Sato T; Akiyama F; Sakamoto G; Kasumi F; Nakamura Y
    Cancer Res; 1991 Nov; 51(21):5794-9. PubMed ID: 1682035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of loss of alleles on the short arms of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes.
    Takita K; Sato T; Miyagi M; Watatani M; Akiyama F; Sakamoto G; Kasumi F; Abe R; Nakamura Y
    Cancer Res; 1992 Jul; 52(14):3914-7. PubMed ID: 1617666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.
    Radford DM; Fair KL; Phillips NJ; Ritter JH; Steinbrueck T; Holt MS; Donis-Keller H
    Cancer Res; 1995 Aug; 55(15):3399-405. PubMed ID: 7614479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern of gene alterations in intraductal breast neoplasms associated with histological type and grade.
    Tsuda H; Fukutomi T; Hirohashi S
    Clin Cancer Res; 1995 Mar; 1(3):261-7. PubMed ID: 9815981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.
    Sato T; Tanigami A; Yamakawa K; Akiyama F; Kasumi F; Sakamoto G; Nakamura Y
    Cancer Res; 1990 Nov; 50(22):7184-9. PubMed ID: 1977515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity at selective sites on chromosomes 13 and 17 in human breast carcinoma.
    Thorlacius S; Jonasdottir O; Eyfjord JE
    Anticancer Res; 1991; 11(4):1501-7. PubMed ID: 1746906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ("clinging ductal carcinoma in situ"): a simulator of normal mammary epithelium.
    Moinfar F; Man YG; Bratthauer GL; Ratschek M; Tavassoli FA
    Cancer; 2000 May; 88(9):2072-81. PubMed ID: 10813719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p.
    Ogawa O; Habuchi T; Kakehi Y; Koshiba M; Sugiyama T; Yoshida O
    Cancer Res; 1992 Apr; 52(7):1881-5. PubMed ID: 1348014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelic loss on a chromosome 17 in ductal carcinoma in situ of the breast.
    Radford DM; Fair K; Thompson AM; Ritter JH; Holt M; Steinbrueck T; Wallace M; Wells SA; Donis-Keller HR
    Cancer Res; 1993 Jul; 53(13):2947-9. PubMed ID: 8391383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type.
    Vos CB; ter Haar NT; Rosenberg C; Peterse JL; Cleton-Jansen AM; Cornelisse CJ; van de Vijver MJ
    Br J Cancer; 1999 Dec; 81(8):1410-8. PubMed ID: 10604741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma.
    Shiseki M; Kohno T; Nishikawa R; Sameshima Y; Mizoguchi H; Yokota J
    Cancer Res; 1994 Nov; 54(21):5643-8. PubMed ID: 7923210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of chromosome 17p loci in breast cancer cells detected by fluorescence in situ hybridization.
    Matsumura K; Kallioniemi A; Kallioniemi O; Chen L; Smith HS; Pinkel D; Gray J; Waldman FM
    Cancer Res; 1992 Jun; 52(12):3474-7. PubMed ID: 1350754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
    Phelan CM; Borg A; Cuny M; Crichton DN; Baldersson T; Andersen TI; Caligo MA; Lidereau R; Lindblom A; Seitz S; Kelsell D; Hamann U; Rio P; Thorlacius S; Papp J; Olah E; Ponder B; Bignon YJ; Scherneck S; Barkardottir R; Borresen-Dale AL; Eyfjörd J; Theillet C; Thompson AM; Larsson C
    Cancer Res; 1998 Mar; 58(5):1004-12. PubMed ID: 9500463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q.
    Devilee P; van Vliet M; van Sloun P; Kuipers Dijkshoorn N; Hermans J; Pearson PL; Cornelisse CJ
    Oncogene; 1991 Sep; 6(9):1705-11. PubMed ID: 1681492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concordant deletions of chromosome 3p and loss of heterozygosity for chromosomes 13 and 17 in small cell lung carcinoma.
    Mori N; Yokota J; Oshimura M; Cavenee WK; Mizoguchi H; Noguchi M; Shimosato Y; Sugimura T; Terada M
    Cancer Res; 1989 Sep; 49(18):5130-5. PubMed ID: 2569931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelotype study of primary hepatocellular carcinoma.
    Fujimori M; Tokino T; Hino O; Kitagawa T; Imamura T; Okamoto E; Mitsunobu M; Ishikawa T; Nakagama H; Harada H
    Cancer Res; 1991 Jan; 51(1):89-93. PubMed ID: 1670995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent deletions involving chromosomes 1, 5, 17, and 18 in colorectal carcinoma: possible role in biological and clinical behavior of tumors.
    Gerdes H; Chen Q; Elahi AH; Sircar A; Goldberg E; Winawer D; Urmacher C; Winawer SJ; Jhanwar SC
    Anticancer Res; 1995; 15(1):13-24. PubMed ID: 7733622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors.
    Presti JC; Rao PH; Chen Q; Reuter VE; Li FP; Fair WR; Jhanwar SC
    Cancer Res; 1991 Mar; 51(5):1544-52. PubMed ID: 1671759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Accumulation of genetic alterations during human tumor progression].
    Yokota J; Ookawa K
    Gan To Kagaku Ryoho; 1993 Feb; 20(3):321-5. PubMed ID: 8094949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.